GlassScriptPhysician profile
Alison A Mcbride
NPI 1548741614
$9,161.60
in general payments reported to CMS, 2019-2025
34 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,475 · 2022: $2,352 · 2023: $2,116 · 2024: $1,542 · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,335.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,683.11 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,459.66 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $925.62 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $778.27 | 2021-2025 | Farxiga, Wainua, Brilinta |
| Amgen INC. | $718.22 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $569.26 | 2021-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $550.26 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $373.93 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $365.54 | 2021-2025 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $285.94 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $218.56 | 2021-2025 | Symplicity G3, Ffrangio |
| Heartflow, INC. | $166.61 | 2025 | |
| Esperion Therapeutics, INC. | $157.74 | 2021-2024 | Nexletol |
| Edwards Lifesciences Corporation | $99.51 | 2024 | Sapien 3 Ultra Resilia |
| Atricure, INC. | $98.19 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $96.75 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $68.58 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.71 | 2023-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $49.99 | 2023-2025 | Opsumit, Uptravi |
| Irhythm Technologies, INC. | $49.43 | 2022-2023 | Zio Xt Patch |
| Siemens Medical Solutions USA, INC. | $43.79 | 2023-2024 | Artis Icono Floor |
| Kiniksa Pharmaceuticals, LTD. | $42.12 | 2023 | Arcalyst |
| Amarin Pharma, INC. | $40.68 | 2022 | |
| Alnylam Pharmaceuticals INC. | $34.60 | 2025 | Amvuttra |
| Philips North America LLC | $30.94 | 2022 | |
| Cardiva Medical, INC. | $26.98 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $26.65 | 2021 | |
| Genzyme Corporation | $25.11 | 2025 | |
| Medicomp INC | $20.48 | 2022 | |
| Lantheus Medical Imaging, INC. | $20.33 | 2024 | |
| United Therapeutics Corporation | $20.26 | 2025 | Tyvaso |
| Daiichi Sankyo INC. | $16.61 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $16.17 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.00 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.